multiplexed sample: Homo sapiens (male, 70 years) substantia nigra tissue associated with Parkinson's disease, mild cognitive impairment; Homo sapiens (male, 85 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 70 years) substantia nigra tissue associated with Parkinson's disease, mild cognitive impairment; Homo sapiens (male, 85 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 70 years) substantia nigra tissue associated with Parkinson's disease, mild cognitive impairment; Homo sapiens (male, 85 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 70 years) substantia nigra tissue associated with Parkinson's disease, mild cognitive impairment; Homo sapiens (male, 85 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 88 years) putamen tissue associated with Parkinson's disease, mild cognitive impairment; Homo sapiens (male, 80 years) substantia nigra tissue associated with Parkinson's disease; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 88 years) putamen tissue associated with Parkinson's disease, mild cognitive impairment; Homo sapiens (male, 80 years) substantia nigra tissue associated with Parkinson's disease; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 70 years) substantia nigra tissue associated with Parkinson's disease, mild cognitive impairment; Homo sapiens (male, 85 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 88 years) putamen tissue associated with Parkinson's disease, mild cognitive impairment; Homo sapiens (male, 80 years) substantia nigra tissue associated with Parkinson's disease; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 88 years) putamen tissue associated with Parkinson's disease, mild cognitive impairment; Homo sapiens (male, 80 years) substantia nigra tissue associated with Parkinson's disease; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 88 years) putamen tissue associated with Parkinson's disease, mild cognitive impairment; Homo sapiens (male, 80 years) substantia nigra tissue associated with Parkinson's disease; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 88 years) putamen tissue associated with Parkinson's disease, mild cognitive impairment; Homo sapiens (male, 80 years) substantia nigra tissue associated with Parkinson's disease; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 70 years) substantia nigra tissue associated with Parkinson's disease, mild cognitive impairment; Homo sapiens (male, 85 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 70 years) substantia nigra tissue associated with Parkinson's disease, mild cognitive impairment; Homo sapiens (male, 85 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 70 years) substantia nigra tissue associated with Parkinson's disease, mild cognitive impairment; Homo sapiens (male, 85 years) middle temporal gyrus tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 10 more samples